Infectious disease: Infotech: finding TB resistance patterns

Article Abstract:

Sharon, PA-based Infectech Inc. and Austin, TX-based Ambion Inc. have combined their technologies at the Veterans Administration Hospital in the Bronx, NY to locate resistance genes in Tuberculosis.

Specialty hospitals exc. psychiatric, Tuberculosis Hospitals, Specialty (except Psychiatric and Substance Abuse) Hospitals, Infectech Inc., Ambion Inc.

---

Cancer: Mayo Clinic/ Digital Gene Technologies: alliance seeks gene targets

Article Abstract:

La Jolla, CA-based Digital Gene Technologies Inc., a total gene expression company, reported that scientists at the Mayo Foundation for Medical Education and Research will use DGT's patented TOGA gene expression profiling technology to study the role of the transcription factor ER81 in the formation of a variety of different tumors. Included in the study are tumors associated with breast and ovarian cancer as well as Ewing's sarcoma.

Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Biological Product (except Diagnostic) Manufacturing, Drugs, Alliances, partnerships, DNA Probes, Cancer & Cell R&D, Cancer research, Digital Gene Technologies Inc.

---

Genetic test: genetic pre-disposition to coronary heart disease

Article Abstract:

Medical Science Inc. reported a research agreement with the University of North Carolina at Chapel hill, to conduct additional clinical utility trials of the company's genetic susceptibility test for coronary disease.

Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Cardiovascular Preparations, Cardiovascular agents, Medical Science Laboratories

Similar abstracts:

• Abstracts: Cancer therapy management-current and emerging in vitro diagnostic technologies. Cancers in women: 2000-2020 will be a decade of change
• Abstracts: Medicine and Applications: Matritech: encouraging results for NMP 66 test. Cancer: Biosafe: prostate cancer awareness program
• Abstracts: Pharmanetics/Aventis: agreement to develop theranostic test for enoxaparin
• Abstracts: Laboratory Corporations of America/ National Genetics Institute. Acquisition: LabCorp/Bio-Diagnostics Laboratories
• Abstracts: Genotypic/Phenotypic resistance testing: HIV drug resistance testing tjo be introduced in the U.S. Homocysteine: first automated homocysteine cleared by FDA

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.